drugset / Trial / NCT01370811
A Relative Efficacy and Safety Study of OC Oral Solution for Sialorrhoea in Patients With Parkinson's Disease
RandomizedCrossoverDouble-blindTreatment
Summary
The purpose of this study is to determine whether OC (oxybutynin and clonidine) oral solution is effective in reducing saliva secretion in patients suffering from Parkinson's Disease with excessive salivation.
Timeline
- Start
- 2011-08
- Primary completion
- 2012-09
- Completion
- 2012-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Clonidine | Other / unclassified | — | Oral |
| Subject | Oxybutynin | Small molecule | — | Oral |
Indications
No indication recorded.